Task: Answer the multiple-choice question.
Question: Which drug exhibits a -34.213% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) O=C(COc1ccccc1Cl)Nc1cc(Cl)ccc1Oc1ccccc1
b.) O=C(CSc1ncn[nH]1)Nc1ccc(Cl)c(S(=O)(=O)N2CCOCC2)c1
c.) Brc1ccc(-c2cnc3n2CCCC3)cc1
d.) O=[N+]([O-])c1ccc(O)c2cccnc12
e.) Cc1cc(N2CCC(C)CC2)n2ncc(-c3ccccc3)c2n1
Answer: c. Brc1ccc(-c2cnc3n2CCCC3)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Brc1ccc(-c2cnc3n2CCCC3)cc1
Brc1ccc(-c2cnc3n2CCCC3)cc1
3-(4-bromophenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine